Bangladesh vs Congo: The number of people with susceptibility test result for rifampicin
Bangladesh
43.54
in 2021
Congo
42.71
in 2021
Bangladesh rank
121st
Congo rank
122nd
The number of people with susceptibility test result for rifampicin over time
- Bangladesh
- Congo
How they compare
Bangladesh currently reports 43.54 against 42.71 in Congo, a difference of 0.83.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Bangladesh ahead.
Bangladesh ranks 121st and Congo ranks 122nd of 146 countries.
Across the 2 decades both report, Bangladesh averaged higher in 1 and Congo in 1.
Head to head by decade
| Decade | Bangladesh | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 26.1 | 15.4 | 10.7 | Bangladesh |
| 2020s | 39.25 | 71.35 | 32.1 | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bangladesh or Congo?
- Bangladesh, at 43.54 against 42.71 in Congo as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bangladesh and Congo?
- 0.83, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Congo?
- 5 years are reported by both, from 2017 to 2021.
- How do Bangladesh and Congo rank globally for the number of people with susceptibility test result for rifampicin?
- Bangladesh ranks 121st and Congo ranks 122nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.